LANCET. INFECTIOUS DISEASES (PRINT)
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
Effectiveness of monovalent and bivalent COVID-19 vaccines.
23:00379-1.
2023-01-01
-
Exploring the potential benefits of mucosal COVID-19 vaccines: opportunities and challenges.
23:363.
2023-01-01
-
Incidence and risk factors for tuberculosis among 420,854 household contacts of tuberculosis patients in the 100 Million Brazilian Cohort (2004-2018) ? a cohort study.
1:1-9.
2023-01-01
-
Incidence and risk factors of tuberculosis among 420-854 household contacts of patients with tuberculosis in the 100 Million Brazilian Cohort (2004-18): a cohort study.
23:S1473-3099.
2023-01-01
-
Incidence and risk factors of tuberculosis among 420854 household contacts of patients with tuberculosis in the 100 Million Brazilian Cohort (2004?18): a cohort study.
23:1-11.
2023-01-01
-
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.
23:856-866.
2023-01-01
-
Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013-19: a surveillance-based cohort study.
23:222-232.
2023-01-01
-
Simian malaria: a narrative review on emergence, epidemiology and threat to global malaria elimination.
2023:01-13.
2023-01-01
-
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era.
00:0000.
2023-01-01
-
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.
11:00510-2-22.
2022-01-01
-
Defining post-COVID condition.
22:316-317.
2022-01-01
-
Dengue vaccines: where are we now and where we are going?.
.:.-..
2022-01-01
-
Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.
22:1-1670.
2022-01-01
-
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.
00:00-00.
2022-01-01
-
Endemic mycoses: geographical distribution is still a work in progress - Authors? reply.
22:451-452.
2022-01-01
-
Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil: a spatiotemporal modelling study.
00:00-00.
2022-01-01
-
Monkeypox in pregnancy: update on current outbreak.
2022:10.1016/S1473-3-1535.
2022-01-01
-
Review of 2022 WHO guidelines on the control and elimination of schistosomiasis.
22:e327-e335.
2022-01-01
-
Vaccination plus previous infection: protection during the omicron wave in Brazil.
00:0000-946.
2022-01-01
-
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.
1:1-1586.
2022-01-01
-
Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses.
21:e123-e133.
2021-01-01
-
Booster doses for inactivated COVID-19 vaccines: if, when, and for whom.
22:430-432.
2021-01-01
-
Can the USA return to pre-COVID-19 normal by July 4?.
-:1.
2021-01-01
-
Clinical interventions for tungiasis (sand flea disease): a systematic review.
21:e234-e245.
2021-01-01
-
Congenital malformations in sub-Saharan Africa-warnings of a silent epidemic?.
25:S1473-3099.
2021-01-01
-
Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease.
21:453.
2021-01-01
-
Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease - Authors' reply.
21:453-454.
2021-01-01
-
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
21:01-13.
2021-01-01
-
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
1:11.
2021-01-01
-
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.
20:1-11.
2021-01-01
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM.
12:S1473-3099(21)0-e386.
2021-01-01
-
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.
21:1907-11.
2021-01-01
-
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019.
.:1.
2021-01-01
-
Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas.
1:1.
2021-01-01
-
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
online:online.
2021-01-01
-
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
20:1129-1140.
2021-01-01
-
Parasitological cure in children infected with Trypanosoma cruzi.
1:1.
2021-01-01
-
Protection against COVID-19: beyond antibodies.
1:1-2.
2021-01-01
-
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12-300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.
20:1.
2021-01-01
-
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
21:1458-1468.
2021-01-01
-
The value of open-source clinical science in pandemic response: lessons from ISARIC.
21:1623-1624.
2021-01-01
-
Validating clinical practice guidelines for the management of children with non-blanching rashes in the UK (PiC): a prospective, multicentre cohort study.
21:569-577.
2021-01-01
-
Zika vaccines: can we solve one problem without creating another one?.
1:1.
2021-01-01
-
A conditional cash transfer programme in Brazil improves leprosy treatment outcomes.
20:1-2.
2020-01-01
-
A minimal common outcome measure set for COVID-19 clinical research.
00:00.
2020-01-01
-
Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data.
1:1-5.
2020-01-01
-
Bilateral median nerve neuritis after chikungunya virus infection.
20:382.
2020-01-01
-
Clinical variables and gene signatures in tuberculosis.
20:1227-1229.
2020-01-01
-
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
21:1-14.
2020-01-01
-
Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean.
00:....
2020-01-01
-
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.
20:20-21.
2020-01-01
-
Effect of a conditional cash transfer programme on leprosy treatment adherence and cure in patients from the nationwide 100 Million Brazilian Cohort: a quasi-experimental study.
1:1-30633.
2020-01-01
-
Global outbreak research: harmony not hegemony.
20:770-772.
2020-01-01
-
High COVID-19 testing rate in Portugal.
20:783.
2020-01-01
-
Importance of the reversed halo sign for diagnosis of mucormycosis.
20:538.
2020-01-01
-
Improving diagnosis of tuberculosis in children.
21:302-303.
2020-01-01
-
Invasive oral and nasal aspergillosis in an immunocompetent child.
20:260.
2020-01-01
-
Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010?15: a population-based, longitudinal study.
1:123-132.
2020-01-01
-
Mycobacterium Tuberculosis Bloodstream Infection Prevalence, Diagnosis, and Mortality Risk in Seriously Ill Adults With HIV: A Systematic Review and Meta-Analysis of Individual Patient Data.
20:742-752.
2020-01-01
-
New WHO guidelines on the management of pregnancy and breastfeeding in the context of Ebola.
20:766-767.
2020-01-01
-
Pregnancy and breastfeeding in the context of Ebola: a systematic review.
20:e149-e158.
2020-01-01
-
Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission.
20:17-19.
2020-01-01
-
Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017.
20:60-79.
2020-01-01
-
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial..
1:1-12.
2020-01-01
-
Serology testing in the COVID-19 pandemic response.
001:000.
2020-01-01
-
The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
20:01-30497.
2020-01-01
-
The forgotten tale of Brazilian phage therapy.
20:e90-e101.
2020-01-01
-
Vaccine development during global epidemics: the Zika experience.
20:1-999.
2020-01-01
-
Viral emergence and immune interplay in flavivirus vaccines.
20:15-17.
2020-01-01
-
Why we should stop using the word leprosy.
20:e75-e78.
2020-01-01
tem uma área de assunto
publisher
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S23772524
International Standard Serial Number (ISSN)